China's Malaria R&D Innovations: A Scoping Review from 2013-2023
- PMID: 40376501
- PMCID: PMC12075444
- DOI: 10.46234/ccdcw2025.105
China's Malaria R&D Innovations: A Scoping Review from 2013-2023
Abstract
Malaria remains a major global health challenge. Understanding the research progress of the potential innovative tools is important for malaria elimination. This scoping review aims to explore China's research and development (R&D) advances from 2013-2023 in addressing the current challenges and contributing to global malaria elimination. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR), this review searched the English and Simplified Chinese data sources from five databases. A total of 11,112 English articles and 2,944 Chinese articles were retrieved. After screening, 44 English and 13 Chinese articles were included. Key advancements were identified in three domains: vector control, pathogen screening and diagnosis, and prevention and treatment. Innovations in vector control include studies such as the use of Serratia strains and symbiont-mediated RNAi approaches to block malaria transmission. Advances in pathogen screening and diagnosis feature biosensor development, AI monitoring technologies, and novel amplification gene and nucleic acid detection technologies. In prevention and treatment, artemisinin-based combination therapies (ACTs) remain a cornerstone, with additional progress in industrial pharmaceuticals and technologies already in field and semi-field-testing stages. This review underscores the importance of leveraging China's R&D capacity to meet global challenges. To maximize impact, we call for global attention to strengthening international collaboration with China in malaria R&D to accelerate the commercialization, regulatory approval, and large-scale deployment of innovations.
Keywords: China; Drug resistance; Insecticide resistance; Malaria R&D; Malaria elimination.
Copyright © 2025 by Chinese Center for Disease Control and Prevention.
Conflict of interest statement
No conflicts of interest.
Figures
Similar articles
-
Domestic trends in malaria research and development in China and its global influence.Infect Dis Poverty. 2017 Jan 10;6(1):4. doi: 10.1186/s40249-016-0222-x. Infect Dis Poverty. 2017. PMID: 28069075 Free PMC article.
-
Community engagement approaches for malaria prevention, control and elimination: a scoping review protocol.BMJ Open. 2021 Oct 5;11(10):e049812. doi: 10.1136/bmjopen-2021-049812. BMJ Open. 2021. PMID: 34610938 Free PMC article.
-
Key contributors to malaria elimination in the People's Republic of China: a scoping review.Malar J. 2024 Aug 27;23(1):259. doi: 10.1186/s12936-024-05090-y. Malar J. 2024. PMID: 39192317 Free PMC article.
-
China's hidden role in malaria control and elimination in Africa.BMJ Glob Health. 2023 Dec 18;8(12):e013349. doi: 10.1136/bmjgh-2023-013349. BMJ Glob Health. 2023. PMID: 38114239 Free PMC article.
-
Seasonal malaria chemoprevention in Africa and China's upgraded role as a contributor: a scoping review.Infect Dis Poverty. 2023 Jul 5;12(1):63. doi: 10.1186/s40249-023-01115-x. Infect Dis Poverty. 2023. PMID: 37403183 Free PMC article.
References
-
-
World Health Organization. World malaria report 2023. Geneva: World Health Organization. 2023. https://www.who.int/publications/i/item/9789240086173. [2025-3-12].
-
-
-
Naidoo K, Oliver SV. Gene drives: an alternative approach to malaria control? Gene Ther 2025;32(1):25-37. http://dx.doi.org/10.1038/s41434-024-00468-8.
-
LinkOut - more resources
Full Text Sources
Miscellaneous